Evidence map›Paper›PMID 38292582›Full record

ArticleJAAD case reports2024

Successful use of dupilumab in recalcitrant pediatric atopic dermatitis-like graft-versus-host disease: A case series.

Lina Belmesk, Afshin Hatami, Julie Powell, Victor Kokta, Jerome Coulombe

Abstract readCase Reports
In one paragraph

Article in JAAD case reports, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Emerging Paediatric Uses of Dupilumab Beyond Approvals.Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology · 2026
    Review
  2. Article
  3. Article
  4. Successful dupilumab treatment in a patient with severe dermatitis following allogenic hematopoietic stem cell transplantation.Allergy, asthma, and clinical immunology : official journal of the Canadian Society of Allergy and Clinical Immunology · 2025
    Article
  5. Article
  6. Review
  7. Successful Use of Dupilumab in Atopic Dermatitis-Like Graft-Versus-Host Disease: A Case Report.Skin research and technology : official journal of International Society for Bioengineering and the Skin (ISBS) [and] International Society for Digital Imaging of Skin (ISDIS) [and] International Society for Skin Imaging (ISSI) · 2024
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Lina BelmeskDivision of Dermatology, Department of Medicine, Universite de Montreal, Montreal, Quebec, Canada.
Afshin HatamiDivision of Dermatology, Department of Pediatrics, CHU Sainte-Justine, Universite de Montreal, Montreal, Quebec, Canada.
Julie PowellDivision of Dermatology, Department of Pediatrics, CHU Sainte-Justine, Universite de Montreal, Montreal, Quebec, Canada.
Victor KoktaDivision of Pathology, Department of Pediatrics, CHU Sainte-Justine, Universite de Montreal, Montreal, Quebec, Canada.
Jerome CoulombeDivision of Dermatology, Department of Pediatrics, CHU Sainte-Justine, Universite de Montreal, Montreal, Quebec, Canada.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

atopic dermatitisdupilumabGvHDimmunologyTh2

Identifiers

PMID38292582
PMCPMC10824674

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.